Company intelligence / Profile preview

Chumakov Federal Scientific Center

Moskovskiy settlement ("Village of Institute"), Moscow, Russiacolab.ws ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Chumakov Federal Scientific Center is a leading Russian institution specializing in medical virology with a long history dating back to its founding by Dr. Mikhail Chumakov. It has developed several globally significant vaccines—including oral polio vaccine—and continues to supply up to ~70% of Russia’s demand for polio-, rabies-, tick-borne encephalitis-, yellow fever-vaccines. The center developed CoviVac—an inactivated whole-virus COVID‑19 vaccine—which was registered by the Russian Ministry of Health in February 2021 and produced at scale through partnerships like Nanolek.

Therapeutic areas
Infectious Diseases
Modalities
VaccineRecombinant proteinMonoclonal antibody
Industry
Biotech
02

Drug pipeline

6 assets

yellow fever vaccine (Chumakov Federal Scientific Center)

Approved

5 more assets in the full pipeline.

Request access →
03

Partnerships

Nanolek (joint venture/manufacturing partnership for CoviVac production)Lomonosov Moscow State UniversitySechenov First Moscow State Medical UniversityKarolinska Institute

Beyond the preview

Go deeper on Chumakov Federal Scientific Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chumakov Federal Scientific Center.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call